We’ll start this week’s roundup with several stories from Washington, D.C. that could have a lasting effect on public health. The FDA continued its campaign against cigarettes, while the Centers for Medicare & Medicaid Services (CMS) gave a much-needed boost to the developers of cancer diagnostics. In its omnibus spending bill, Congress set aside more […]
Original Article: Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks
NEXT ARTICLE